Literature DB >> 15647386

Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.

Aaron W Adamson1, Dillon I Beardsley, Wan-Ju Kim, Yajuan Gao, R Baskaran, Kevin D Brown.   

Abstract

SN1 DNA methylating agents such as the nitrosourea N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) elicit a G2/M checkpoint response via a mismatch repair (MMR) system-dependent mechanism; however, the exact nature of the mechanism governing MNNG-induced G2/M arrest and how MMR mechanistically participates in this process are unknown. Here, we show that MNNG exposure results in activation of the cell cycle checkpoint kinases ATM, Chk1, and Chk2, each of which has been implicated in the triggering of the G2/M checkpoint response. We document that MNNG induces a robust, dose-dependent G2 arrest in MMR and ATM-proficient cells, whereas this response is abrogated in MMR-deficient cells and attenuated in ATM-deficient cells treated with moderate doses of MNNG. Pharmacological and RNA interference approaches indicated that Chk1 and Chk2 are both required components for normal MNNG-induced G2 arrest. MNNG-induced nuclear exclusion of the cell cycle regulatory phosphatase Cdc25C occurred in an MMR-dependent manner and was compromised in cells lacking ATM. Finally, both Chk1 and Chk2 interact with the MMR protein MSH2, and this interaction is enhanced after MNNG exposure, supporting the notion that the MMR system functions as a molecular scaffold at the sites of DNA damage that facilitates activation of these kinases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647386      PMCID: PMC551512          DOI: 10.1091/mbc.e04-02-0089

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  74 in total

1.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

2.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

Authors:  Y Sanchez; C Wong; R S Thoma; R Richman; Z Wu; H Piwnica-Worms; S J Elledge
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

3.  Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.

Authors:  D R Duckett; J T Drummond; A I Murchie; J T Reardon; A Sancar; D M Lilley; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Loss of DNA mismatch repair in acquired resistance to cisplatin.

Authors:  S Aebi; B Kurdi-Haidar; R Gordon; B Cenni; H Zheng; D Fink; R D Christen; C R Boland; M Koi; R Fishel; S B Howell
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

5.  Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.

Authors:  A Umar; M Koi; J I Risinger; W E Glaab; K R Tindall; R D Kolodner; C R Boland; J C Barrett; T A Kunkel
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

6.  DNA replication arrest and tolerance to DNA methylation damage.

Authors:  N Zhukovskaya; P Branch; G Aquilina; P Karran
Journal:  Carcinogenesis       Date:  1994-10       Impact factor: 4.944

Review 7.  Cell cycle control and cancer.

Authors:  L H Hartwell; M B Kastan
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

8.  Recombinant ATM protein complements the cellular A-T phenotype.

Authors:  Y Ziv; A Bar-Shira; I Pecker; P Russell; T J Jorgensen; I Tsarfati; Y Shiloh
Journal:  Oncogene       Date:  1997-07-10       Impact factor: 9.867

9.  The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.

Authors:  J A Mello; S Acharya; R Fishel; J M Essigmann
Journal:  Chem Biol       Date:  1996-07

10.  Defective G2 checkpoint function in cells from individuals with familial cancer syndromes.

Authors:  R S Paules; E N Levedakou; S J Wilson; C L Innes; N Rhodes; T D Tlsty; D A Galloway; L A Donehower; M A Tainsky; W K Kaufmann
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

View more
  31 in total

Review 1.  Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer.

Authors:  Christopher D Heinen
Journal:  DNA Repair (Amst)       Date:  2015-12-02

2.  ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.

Authors:  Ken-ichi Yoshioka; Yoshiko Yoshioka; Peggy Hsieh
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

3.  Interactions of human mismatch repair proteins MutSalpha and MutLalpha with proteins of the ATR-Chk1 pathway.

Authors:  Yiyong Liu; Yanan Fang; Hongbing Shao; Laura Lindsey-Boltz; Aziz Sancar; Paul Modrich
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

4.  Human pluripotent stem cells have a novel mismatch repair-dependent damage response.

Authors:  Bo Lin; Dipika Gupta; Christopher D Heinen
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

5.  Drug-sensitive DNA polymerase δ reveals a role for mismatch repair in checkpoint activation in yeast.

Authors:  Linda J Reha-Krantz; Md Shahjahan P Siddique; Kelly Murphy; Andrea Tam; Michelle O'Carroll; Sam Lou; Amy Schultz; Charles Boone
Journal:  Genetics       Date:  2011-09-16       Impact factor: 4.562

6.  Nuclear reorganization of DNA mismatch repair proteins in response to DNA damage.

Authors:  Adam S Mastrocola; Christopher D Heinen
Journal:  DNA Repair (Amst)       Date:  2009-12-08

7.  Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.

Authors:  Eugene Izumchenko; John Saydi; Kevin D Brown
Journal:  DNA Repair (Amst)       Date:  2012-10-11

8.  MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  Guoming Sun; Shunqian Jin; R Baskaran
Journal:  Exp Cell Res       Date:  2009-09-17       Impact factor: 3.905

9.  Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells.

Authors:  Melanie J Jardim; Qinhong Wang; Ryohei Furumai; Timothy Wakeman; Barbara K Goodman; Xiao-Fan Wang
Journal:  Mol Biol Cell       Date:  2009-07-01       Impact factor: 4.138

10.  MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea.

Authors:  J R McDaid; J Loughery; P Dunne; J C Boyer; C S Downes; R A Farber; C P Walsh
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.